Home/Libera Bio/Olivier R. Jarry
OR

Olivier R. Jarry

CEO

Libera Bio

Therapeutic Areas

Libera Bio Pipeline

DrugIndicationPhase
Undisclosed (Platform-derived)Oncology (e.g., KRAS-mutant cancers)Pre-clinical